A Zepbound savings card lowers tirzepatide cost the most

The sticker price on tirzepatide is brutal. A month of Zepbound pens lists for up to $1,086, and Mounjaro sits right behind at $1,079.77 for any dose. Almost nobody with the right coverage pays that. A zepbound savings card can drop a covered prescription to as little as $25 a month, which is the single biggest lever on what you actually hand over at the pharmacy.

What you pay comes down to two things: which drug you were prescribed, and what your insurance will do. Zepbound and Mounjaro are the same molecule, tirzepatide, sold as two products with two different savings programs. So the real tirzepatide cost swings from $25 to well over a thousand dollars on paperwork you can control. Here is how each path works, with the numbers as they stand in 2026.

The list price is the number almost no one pays

List price is what a pharmacy charges with no insurance and no coupon. For Zepbound, that runs up to $1,086.37 a month for the pen, though lower doses and self-pay formats come in under that. Mounjaro's list price is flatter, $1,079.77 a month whether you are on 2.5 mg or 15 mg. Neither figure reflects what most people pay, but it is the ceiling everything else is measured against.

The dose you're on matters less than you'd expect. Tirzepatide is priced per pen, not per milligram, so climbing the Zepbound dose schedule from 2.5 mg to 15 mg does not raise the pen price. That is why a bare zepbound cost figure sits right next to a mounjaro price figure at the same list tier.

About $25 a month with a covered plan, close to $1,086 without help. Same drug, two very different receipts.

How the Zepbound savings card works

The zepbound savings card splits into two lanes. If you have commercial insurance that covers Zepbound, the card brings your share to as little as $25 for a 1-month, 2-month, or 3-month fill, up to a maximum of $1,300 in savings per calendar year. That is the best case, and it is why so many people ask how much is Zepbound before they even check their formulary.

If your commercial plan doesn't cover Zepbound, the same card still helps, and you pay as low as $299 for a one-month fill. Government coverage is the catch. Medicare, Medicaid, and other federal plans can't be combined with the card, so those patients fall back to list price or other programs. The full rules sit in Lilly's published savings terms.

Who the $25 price is actually for

• Commercial insurance that covers Zepbound
• A valid prescription for the pen or vial
• Not enrolled in Medicare or Medicaid
• Fills bought within the card's annual cap

Mounjaro copay card follows different rules

Mounjaro is tirzepatide approved for type 2 diabetes, and its help is stricter. The mounjaro copay card brings eligible commercially insured patients with a diabetes diagnosis to as little as $25 a month, but it won't work with Medicare, Medicaid, TRICARE, or any federal plan. If you're uninsured, the card is closed to you, which is the sharpest break from the Zepbound side.

That leaves a real gap for cash payers. Someone asking how much is Mounjaro with insurance and a covered plan sees that $25 figure, while an uninsured neighbor on the same drug faces the full mounjaro cost near list. It's one molecule doing one job, priced by which door you walked through. For where those doses top out, see how the tirzepatide ladder tops out.

The Mounjaro copay card is closed to anyone on Medicare or paying cash, no matter the diagnosis.

What tirzepatide costs without insurance

Without insurance, the two products split again. Zepbound has a self-pay route through LillyDirect that Mounjaro doesn't match. Zepbound self-pay pens start at $299 a month for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, and $699 for the 10 mg through 15 mg doses. So even zepbound without insurance can land near $299 early in a protocol.

Mounjaro has no equivalent cash program, so an uninsured patient sits closer to the $1,080 list price. A goodrx mounjaro coupon trims that only a little, to roughly $990 to $1,050 a month at most pharmacies, according to published Mounjaro pricing. Lilly Cares, the maker's charity program, can supply Mounjaro free to people at or below 400 percent of the federal poverty level, which is $63,840 for an individual in 2026.

• Zepbound self-pay through LillyDirect from $299
• A GoodRx coupon on the Mounjaro cash price
• Lilly Cares for lower-income patients
• Buying a 3-month fill to spread the savings

What the savings actually add up to over a year

Play the numbers forward and the gap is stark. At the covered-plan price, tirzepatide runs about $25 a month, or roughly $300 a year, though the savings card caps help at $1,300 a year, so late fills can cost more once you hit the ceiling. Pay the Zepbound self-pay rate of $299 a month and you're near $3,588 a year. Pay list for Mounjaro and you're past $12,900.

The point isn't which drug is cheaper, because that depends entirely on your coverage. It's that the difference between $300 and $13,000 a year is mostly paperwork: a formulary check, a savings card enrollment, and refills timed so you don't lose a discount. A quick answer to how much is Zepbound or Mounjaro rarely captures that, because the real answer is your plan.

The distance between $300 and $13,000 a year is mostly paperwork, not pharmacology.

Keep the receipts, refills, and cards in one place

A savings card only helps if you use it before it lapses. The current cards run through December 31, 2026, self-pay maintenance pricing can require a refill within about 45 days to hold the lowest rate, and the annual cap resets on a calendar you have to watch. Miss any of those and your tirzepatide cost quietly climbs back toward list.

This is where plain record-keeping pays for itself. Logging each fill, its price, and the next refill date turns a scramble into a routine. Redose tracks vial inventory and reorder timing, and its dose calculator shows the syringe units behind each tirzepatide dose. Redose is for tracking and record-keeping only, so pricing and prescriptions stay between you and your prescriber.

What to log every refill

• The price you paid and the pharmacy
• Which savings card or coupon applied
• The date your next refill is due
• How close you are to the annual cap

Common questions about tirzepatide cost

How much is Zepbound with a savings card?

With commercial insurance that covers Zepbound, the savings card can bring a 1-month, 2-month, or 3-month fill to as little as $25, up to $1,300 in help per year. If your plan doesn't cover it, the card still lands you near $299 a month, and LillyDirect self-pay starts at that same $299 for the lowest dose.

How much is Mounjaro without insurance?

Without insurance, Mounjaro is close to its $1,079.77 list price, because it has no manufacturer self-pay program like Zepbound's. A GoodRx coupon can trim it to roughly $990 to $1,050 a month, and Lilly Cares may cover it entirely for patients at or below 400 percent of the federal poverty level.

How much is Mounjaro with insurance?

With commercial insurance and a type 2 diabetes diagnosis, the Mounjaro copay card can bring eligible patients to as little as $25 a month. Medicare and Medicaid plans are excluded, so those patients lean on Part D coverage, where recent rules cap annual out-of-pocket drug spending at $2,100.

Does GoodRx lower the Mounjaro price?

A little. A goodrx mounjaro coupon usually knocks the cash price to about $990 to $1,050 a month, which is modest against a $1,080 list. It helps most when you have no other discount, but it won't approach the $25 a covered savings card delivers.

Your tirzepatide cost is a moving target, so treat it like one. Track every fill, the card you used, and the refill date, and the $25 price stays $25 instead of drifting back to list. Redose keeps your doses, vial inventory, reminders, and side-effect notes in one private log so the savings never slip through a gap. Get the app here: iOS.